Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

Olivier Corbeil; Anne Marie Essiambre; Laurent Béchard; Audrey Anne Roy; Maxime Huot-Lavoie; Sébastien Brodeur; Ranjith Chandrasena; Chantale Thériault; Candice Crocker; Jean Pierre Melun; Phil Tibbo; Marie France Demers; Marc André Roy

doi:10.1177/20451253221136021

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

Olivier Corbeil, Anne Marie Essiambre, Laurent Béchard, Audrey Anne Roy, Maxime Huot-Lavoie, Sébastien Brodeur, Ranjith Chandrasena, Chantale Thériault, Candice Crocker, Jean Pierre Melun, Phil Tibbo, Marie France Demers, Marc André Roy

科研成果: 期刊稿件 › 文章 › 同行评审

5 引用（Scopus）

源语言	英语
期刊	Therapeutic Advances in Psychopharmacology
卷	12
DOI	https://doi.org/10.1177/20451253221136021
出版状态	已出版 - 2022
已对外发布	是

!!!ASJC Scopus Subject Areas

心理学（杂项）
药理学、毒理学和药学（杂项）

访问文件

10.1177/20451253221136021

其它文件与链接

引用此

Corbeil, O., Essiambre, A. M., Béchard, L., Roy, A. A., Huot-Lavoie, M., Brodeur, S., Chandrasena, R., Thériault, C., Crocker, C., Melun, J. P., Tibbo, P., Demers, M. F., & Roy, M. A. (2022). Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation. Therapeutic Advances in Psychopharmacology, 12. https://doi.org/10.1177/20451253221136021

Corbeil, O, Essiambre, AM, Béchard, L, Roy, AA, Huot-Lavoie, M, Brodeur, S, Chandrasena, R, Thériault, C, Crocker, C, Melun, JP, Tibbo, P, Demers, MF & Roy, MA 2022, 'Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation', Therapeutic Advances in Psychopharmacology, 卷 12. https://doi.org/10.1177/20451253221136021

@article{7042b3ee416746ec8f90bd86e58a9d03,

title = "Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation",

keywords = "antipsychotic, long-acting injectable, naturalistic setting, paliperidone palmitate 1-monthly, paliperidone palmitate 3-monthly, psychotic disorder, relapse, schizophrenia",

author = "Olivier Corbeil and Essiambre, {Anne Marie} and Laurent B{\'e}chard and Roy, {Audrey Anne} and Maxime Huot-Lavoie and S{\'e}bastien Brodeur and Ranjith Chandrasena and Chantale Th{\'e}riault and Candice Crocker and Melun, {Jean Pierre} and Phil Tibbo and Demers, {Marie France} and Roy, {Marc Andr{\'e}}",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2022.",

year = "2022",

doi = "10.1177/20451253221136021",

language = "English",

volume = "12",

journal = "Therapeutic Advances in Psychopharmacology",

issn = "2045-1253",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

AU - Corbeil, Olivier

AU - Essiambre, Anne Marie

AU - Béchard, Laurent

AU - Roy, Audrey Anne

AU - Huot-Lavoie, Maxime

AU - Brodeur, Sébastien

AU - Chandrasena, Ranjith

AU - Thériault, Chantale

AU - Crocker, Candice

AU - Melun, Jean Pierre

AU - Tibbo, Phil

AU - Demers, Marie France

AU - Roy, Marc André

N1 - Publisher Copyright: © The Author(s), 2022.

PY - 2022

Y1 - 2022

KW - antipsychotic

KW - long-acting injectable

KW - naturalistic setting

KW - paliperidone palmitate 1-monthly

KW - paliperidone palmitate 3-monthly

KW - psychotic disorder

KW - relapse

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85156228269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85156228269&partnerID=8YFLogxK

U2 - 10.1177/20451253221136021

DO - 10.1177/20451253221136021

M3 - Article

AN - SCOPUS:85156228269

SN - 2045-1253

VL - 12

JO - Therapeutic Advances in Psychopharmacology

JF - Therapeutic Advances in Psychopharmacology

ER -

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此